Late toxicity and quality of life from GETUG-AFU 22 study: A randomized phase II trial comparing 6 months of degarelix in combination with radiotherapy to radiotherapy alone for patients with detectable PSA after radical prostatectomy
Sargos, P., Guerif, S., Fraisse, J., Meyer, E., Supiot, S., Lagneau, E., Deniaud-Alexandre, E., Rochin, P., Benyoucef, A., Cartier, L., Hamidou, H., Hasbini, A., Crehange, G., Pommier, P., De Laroche, G., Pelissier, S., Gross, E., Fourneret, P., Salomon, L., Latorzeff, I.
Published in European urology open science (Online) (01.07.2020)
Published in European urology open science (Online) (01.07.2020)
Get full text
Journal Article
Effect of the calcium antagonist Felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril : V-HeFT III
COHN, J. N, ZIESCHE, S, LOSS, L, SMITH, R, ANAND, I, DUNKMAN, W. B, LOEB, H, CINTRON, G, BODEN, W, BARUCH, L, ROCHIN, P
Published in Circulation (New York, N.Y.) (05.08.1997)
Published in Circulation (New York, N.Y.) (05.08.1997)
Get full text
Journal Article
Effect of the calcium antagonist felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril: V-HeFT III. Vasodilator-Heart Failure Trial (V-HeFT) Study Group
Cohn, J N, Ziesche, S, Smith, R, Anand, I, Dunkman, W B, Loeb, H, Cintron, G, Boden, W, Baruch, L, Rochin, P, Loss, L
Published in Circulation (New York, N.Y.) (05.08.1997)
Get full text
Published in Circulation (New York, N.Y.) (05.08.1997)
Journal Article